Suvorexant Impurity 1 | CAS 1030377-32-2 - Request Quote
Suvorexant Impurity 1
| SZ CAT No: | SZ-S052004 |
| CAS No | 1030377-32-2 |
| Mol.F. | C16H21N5O |
| Mol.Wt. | 299.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Suvorexant Impurity 1 is chemically (R)-(7-Methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone. Suvorexant Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Suvorexant Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Suvorexant.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1030377-32-2
Purchase 1030377-32-2
Order 1030377-32-2
Enquire 1030377-32-2
price of 1030377-32-2
1030377-32-2 Supplier
1030377-32-2 Manufacturer
1030377-32-2 Exporter
buy high quality Suvorexant Impurity 1
Purchase Suvorexant Impurity 1
Suvorexant Impurity 1 suppliers
Suvorexant Impurity 1 manufacturers
Suvorexant Impurity 1 price
Order Suvorexant Impurity 1
Enquire Suvorexant Impurity 1
Suvorexant Impurity 1 cost
Suvorexant Impurity 1 Supplier
Suvorexant Impurity 1 Distributor
Suvorexant Impurity 1 for Method Validation
Suvorexant Reference Standard
Suvorexant Impurity 1 for ANDA Filing
Suvorexant Impurity 1 for Forced Degradation Studies
Suvorexant Impurity 1 Identification Standards
Suvorexant Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.